Skip to main navigationSkip to News Headlines
NJ Division of Consumer Affairs
Global Navigation
Division of Consumer Affairs
The State of New Jersey Office of The Attorney General (Dept. of Law & Public Safety) The State of New Jersey NJ Home Services A to Z Departments/Agencies OAG Frequently Asked Questions
OAG Home
OAG Contact
Division of Consumer Affairs Alerts and Recalls
Division of Consumer Affairs Alerts and Recalls
Office of the Attorney General Homepage Division of Consumer Affairs, Director
Division of Consumer Affairs, Director
Division of Alcoholic Beverage Control
Division of Consumer Affairs
Division of Consumer Affairs Highlights
Division of Consumer Affairs Topics in a A-Z List Format
Office of Consumer Protection (OCP)
New Jersey Bureau of Securities
Office of Weights and Measures
Legalized Games of Chance Control Commission
Alternative Dispute Resolution
Professions and Occupations List
Contact the Division of Consumer Affairs
Division of Consumer Affairs in Spanish
Division of Criminal Justice
Division on Civil Rights
Division of Gaming Enforcement
Division of Highway Traffic Safety
Division of Law
Juvenile Justice Commission
NJ Racing Commission
State Athletic Control Board
Division of NJ State Police
Victims of Crime Compensation Office
Subscribe to Buyer Beware Alerts
OPRA - Open Public Records Act
Download Free PDF Reader
Board of Pharmacy

Welcome to the Web site of the Board of Pharmacy.

This board licenses and regulates pharmacies (in state and out of state), pharmacists, pharmacy technicians and pharmacy interns in the State of New Jersey. Inquiries or complaints may be forwarded to Mr. Anthony Rubinaccio, Executive Director, Board of Pharmacy, PO Box 45013, Newark, NJ 07101, (973) 504-6450 or via e-mail.

New Jersey Prescription Blanks (NJPBs) Information:

On February 18, 2014, the Division of Consumer Affairs adopted new regulations which will incorporate print-based security features into all New Jersey Prescription Blanks (NJPBs). There are a few key dates that you should be aware of:

May 18, 2014

After this day, approved New Jersey Prescription Blank Printer Vendors will no longer be able to sell the "old" NJPB (blue front, green back); only the new design will be permitted to be offered for sale.

August 18, 2014

The "old" NJPBs may be used by practitioners for validly written prescriptions dated on or before August 18, 2014.

After this date, practitioners must use the new NJPBs to issue prescriptions written for their patients.

Note: Patient prescriptions originally written on or before August 18, 2014 will be filled at a New Jersey pharmacy pursuant to the guidelines set forth in N.J.A.C. 13:39-7.3 for non-Controlled Dangerous Substances (non-CDS) and N.J.A.C. 13:45H-7.5 for Controlled Dangerous Substances (CDS).
  • Prescribers may place an order for New Jersey Prescription Blanks either with an approved Printer Vendor or an approved Sales Representative who works with an approved Printer Vendor.


New Alerts

Pharmacy Technicians
Requirement to Obtain and Maintain Active Registrations

It has come to the attention of the Board of Pharmacy that a number of Pharmacy Technicians may not be abiding by the regulations related to obtaining and maintaining an active registration as a Pharmacy Technician in the State of New Jersey. Effective immediately, Pharmacy Technicians who do not hold a valid registration, and who fall into one of the three groups outlined in the attached memo, have until May 15, 2014 to come into full compliance with the requirements of N.J.A.C. 13:39-6.6 "Pharmacy technician registration and pharmacy technician applicants". All Pharmacists-in-Charge and those individuals performing the duties of Pharmacy Technicians are encouraged to review this information in it's entirety via the link below.
(View Information)

Naloxone Dispensing Guidance for Pharmacists
On May 2, 2013, Governor Christie signed into law the Overdose Prevention Act (P.L. 2013, c. 46, N.J.S.A. 254:6J-1 et seq.) One of the purposes of the law is to reduce the number of opioid overdose deaths by making Naloxone, an opioid antidote, more widely available and accessible. The statute allows health care professionals to prescribe or dispense Naloxone, or similarly acting drugs, not only to patients who may be in danger of overdosing, but also to first responders, family members, caregivers, or peers who are not at risk for an opioid overdose but who, "in the judgment of a physician, may be in a position to assist another individual during an overdose." While the Board works to draft regulations to implement this new law, they have developed a Guidance document to assist pharmacists in complying with this new law and existing regulations. Pharmacists are encouraged to review this information in it's entirety via the link below.
(View Information)

Public Hearing in Reference to Jacobs Pharmacy
On December 17, 2013 there will be a Public Hearing in reference to Jacobs Pharmacy located at 370 South Orange Avenue, Newark, NJ 07103. The hearing will be held at 124 Halsey Street, Newark, NJ 07102, in the Essex Conference Room on the 7th floor, at 1:00 p.m.
(View Notice)

Three N.J. Pharmacists Surrender Their Licenses
Three N.J. Pharmacists Surrender Their Licenses Amid Pending Criminal Charges in Interstate Prescription Drug Distribution Ring
(View Information / Posted 11/18/13)

Project Medicine Drop
Allows consumers to dispose of unused and expired medications anonymously, seven days a week, 365 days a year, at "prescription drug drop boxes" located within the headquarters of participating police departments.
(Visit Web Site / Find a Drop Box Location)

Practices for Pharmacy Security
The best practices outlined are recommendations to achieve a safe operating environment for pharmacy employees and cust omers and lower the potential for adverse events.
(View Information / Posted 5/1/13)

Med Prep Consulting Inc.:
New Jersey Attorney General Seeks to Revoke the License of Med Prep Pharmacy and its Pharmacist-in-Charge Due to Multiple Alleged Violations

In Agreement with State Pharmacy Board, Monmouth County Pharmacy Temporarily Halts Operations Following Recall of Intravenous Products

Proposal
Compounding Sterile and Non-Sterile Preparations in Retail and Institutional Pharmacies
(View Information / Approved 3/4/13)

Fungal Meningitis Outbreak
(View Information / Updated 3/4/13)

Adoption
The Board of Pharmacy recently adopted new rules, along with the Board of Medical Examiners, concerning: Collaborative Practice Arrangements between physicians and pharmacists.
(View Adoption / Adopted 2/17/13)

Adoption
The Division of Consumer Affairs recently adopted amendments and new rules concerning: electronic prescriptions; specifically to permit the electronic prescribing of CDS.
(View Adoption / Adopted 1/7/13)

Information
Safe Syringe & Assistance for Substance Abuse Issues
(View Information 10/9/12)

Revised Statutes
Title 2C of the New Jersey Statutes and Title 45 of the Revised Statutes Concerning the sale and possession of hypodermic syringes and needles, and supplementing.
(View Revision / Approved 1/17/12)

 

   
Contact Us | Privacy Notice | Legal Statement | Accessibility Statement
NJ Home Logo
Divisional: DCA Home | Complaint Forms | Proposals | Adoptions | Contact DCA
Departmental: OAG Home | Contact OAG | About OAG | OAG News | OAG FAQs
Statewide: NJ Home | Services A to Z | Departments/Agencies | FAQs
Copyright State of New Jersey
This page is maintained by DCA. Comments/Questions: email

Page last modified: